By analyzing thousands of genetic risk variants, a new algorithm developed by Columbia researchers may be able to predict your risk of developing chronic kidney disease decades before onset.
Using advanced imaging methods, researchers have gained insight into how a common target of drugs sends cellular signals, a finding that may lead to better and more precise therapeutics.
The Columbia Stem Cell Initiative, which provides support to more than 50 laboratories across the university engaged in stem cell research, moved this spring into new facilities.
Four physician-scientists at the Vagelos College of Physicians and Surgeons have been named 2019 Louis V. Gerstner Jr. Scholars, and a fifth has been named a 2019 Louis V. Gerstner Jr. Merit Awardee.
Scientists at Columbia have developed a gene-editing tool—using jumping genes—that inserts any DNA sequence into the genome without cutting, fixing a major shortcoming of existing CRISPR technology.
A new study suggests that providers make the same number of wrong-patient errors regardless of the number of electronic patient records they could have open at a time.
Columbia engineers and surgeons show that new salvage methods can recondition severely damaged lungs to meet transplantation criteria and could make more lungs available for patients.
A new study suggests that depression and GI trouble sometimes spring from the same source—low serotonin—and identifies a potential treatment that could ease both conditions.
Four researchers at VP&S have been named 2019 Schaefer Research Scholars and will pursue new ideas in cancer metastasis, neurodegenerative disease, and compulsive behavior.
A new study from Columbia pediatricians found that new mothers are more receptive to educational materials that contain facts, not criticism, about sugary drinks.